|
1
|
Liu YT, Lei CY, Zhong LM. Research Advancements on the Correlation Between Spontaneous Intracerebral Hemorrhage of Different Etiologies and Imaging Markers of Cerebral Small Vessel Disease. Neuropsychiatr Dis Treat 2024; 20:307-316. [PMID: 38405425 PMCID: PMC10893791 DOI: 10.2147/ndt.s442334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 01/24/2024] [Indexed: 02/27/2024] Open
Abstract
Objective The purpose of this review is to identify the correlation between ICH and CSVD imaging markers under SMASH-U classification by searching and analyzing a large number of literatures in recent years, laying a theoretical foundation for future clinical research. At the same time, by collecting clinical data to evaluate patient prognosis, analyzing whether there are differences or supplements between clinical trial conclusions and previous theories, and ultimately guiding clinical diagnosis and treatment through the analysis of imaging biomarkers. Methods In this review, by searching CNKI, Web of Science, PubMed, FMRS and other databases, the use of "spontaneous intracerebral hemorrhage", "hypertensive hemorrhagic cerebral small vessel disease", "cerebral small vessel disease imaging", "Based cerebral small vessel diseases", "SMASH the -u classification" and their Chinese equivalents for the main search term. We focused on reading and analyzing hundreds of relevant literatures in the last decade from August 2011 to April 2020, and also included some earlier literatures with conceptual data sources. After screening and ranking the degree of relevance to this study, sixty of them were cited for analysis and elaboration. Results In patients with ICH, the number of cerebral microbleeds in lobes, basal ganglia, and the deep brain is positively correlated with ICH volume and independently correlated with neurological functional outcomes; white matter hyperintensity severity is positively correlated with ICH recurrence risk; multiple lacunar infarction independently predict the risk of ICH; severe brain atrophy is an independent risk factor for a poor prognosis in the long term in patients diagnosed with ICH; and the number of enlarged perivascular spaces is correlated with ICH recurrence. However, small subcortical infarct and ICH are the subject of few studies. Higher CSVD scores are independently associated with functional outcomes at 90 days in patients diagnosed with ICH.
Collapse
Affiliation(s)
- Yu-Tong Liu
- Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, People’s Republic of China
| | - Chun-Yan Lei
- Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, People’s Republic of China
| | - Lian-Mei Zhong
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, People’s Republic of China
| |
Collapse
|
|
2
|
Dimaras T, Merkouris E, Tsiptsios D, Christidi F, Sousanidou A, Orgianelis I, Polatidou E, Kamenidis I, Karatzetzou S, Gkantzios A, Ntatsis C, Kokkotis C, Retsidou S, Aristidou M, Karageorgopoulou M, Psatha EA, Aggelousis N, Vadikolias K. Leukoaraiosis as a Promising Biomarker of Stroke Recurrence among Stroke Survivors: A Systematic Review. Neurol Int 2023; 15:994-1013. [PMID: 37606397 PMCID: PMC10443317 DOI: 10.3390/neurolint15030064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 08/11/2023] [Accepted: 08/18/2023] [Indexed: 08/23/2023] Open
Abstract
Stroke is the leading cause of functional disability worldwide, with increasing prevalence in adults. Given the considerable negative impact on patients' quality of life and the financial burden on their families and society, it is essential to provide stroke survivors with a timely and reliable prognosis of stroke recurrence. Leukoaraiosis (LA) is a common neuroimaging feature of cerebral small-vessel disease. By researching the literature of two different databases (MEDLINE and Scopus), the present study aims to review all relevant studies from the last decade, dealing with the clinical utility of pre-existing LA as a prognostic factor for stroke recurrence in stroke survivors. Nineteen full-text articles published in English were identified and included in the present review, with data collected from a total of 34,546 stroke patients. A higher rate of extended LA was strongly associated with stroke recurrence in all stroke subtypes, even after adjustment for clinical risk factors. In particular, patients with ischemic stroke or transient ischemic attack with advanced LA had a significantly higher risk of future ischemic stroke, whereas patients with previous intracerebral hemorrhage and severe LA had a more than 2.5-fold increased risk of recurrent ischemic stroke and a more than 30-fold increased risk of hemorrhagic stroke. Finally, in patients receiving anticoagulant treatment for AF, the presence of LA was associated with an increased risk of recurrent ischemic stroke and intracranial hemorrhage. Because of this valuable predictive information, evaluating LA could significantly expand our knowledge of stroke patients and thereby improve overall stroke care.
Collapse
Affiliation(s)
- Theofanis Dimaras
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Ermis Merkouris
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Dimitrios Tsiptsios
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Foteini Christidi
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Anastasia Sousanidou
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Ilias Orgianelis
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Efthymia Polatidou
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Iordanis Kamenidis
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Stella Karatzetzou
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Aimilios Gkantzios
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Christos Ntatsis
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Christos Kokkotis
- Department of Physical Education and Sport Science, Democritus University of Thrace, 69100 Komotini, Greece; (C.K.); (M.A.); (M.K.); (N.A.)
| | - Sofia Retsidou
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Maria Aristidou
- Department of Physical Education and Sport Science, Democritus University of Thrace, 69100 Komotini, Greece; (C.K.); (M.A.); (M.K.); (N.A.)
| | - Maria Karageorgopoulou
- Department of Physical Education and Sport Science, Democritus University of Thrace, 69100 Komotini, Greece; (C.K.); (M.A.); (M.K.); (N.A.)
| | - Evlampia A. Psatha
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| | - Nikolaos Aggelousis
- Department of Physical Education and Sport Science, Democritus University of Thrace, 69100 Komotini, Greece; (C.K.); (M.A.); (M.K.); (N.A.)
| | - Konstantinos Vadikolias
- Neurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece; (T.D.); (E.M.); (F.C.); (A.S.); (E.P.); (I.K.); (S.K.); (A.G.); (C.N.); (S.R.); (E.A.P.); (K.V.)
| |
Collapse
|
|
3
|
Yang MJ, Guo SL, Sin DD. Reply: Association between triple therapy and major adverse cardiovascular events in COPD patients. Eur Respir J 2023; 61:13993003.02332-2022. [PMID: 36549713 DOI: 10.1183/13993003.02332-2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Accepted: 12/12/2022] [Indexed: 12/24/2022]
Affiliation(s)
- Ming-Jin Yang
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Shu-Liang Guo
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Shu-Liang Guo and Don D. Sin contributed equally to this article as lead authors and supervised the work
| | - Don D Sin
- Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
- Centre for Heart Lung Innovation, University of British Columbia, and St. Paul's Hospital, Vancouver, BC, Canada
- Shu-Liang Guo and Don D. Sin contributed equally to this article as lead authors and supervised the work
| |
Collapse
|
|
4
|
Wan Y, Guo H, Bi R, Chen S, Shen J, Li M, Xia Y, Zhang L, Sun Z, Chen X, Cai Z, Wang Z, Gong D, Xu J, Zhu D, Hu B, He Q. Clinical and Prognostic Characteristics of Recurrent Intracerebral Hemorrhage: A Contrast to First-Ever ICH. Front Aging Neurosci 2022; 14:860571. [PMID: 35493945 PMCID: PMC9047504 DOI: 10.3389/fnagi.2022.860571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2022] [Accepted: 02/28/2022] [Indexed: 11/18/2022] Open
Abstract
This study aimed to compare clinical and prognostic characteristics between recurrent and first-ever ICH. Four thousand twelve patients entered the study, and 64% of them were male. The median age is 62 years (interquartile range, 55–71). Among them, 3,750 (93.5%) patients had no experience of previous ICH, and 262 (6.5%) patients were considered as recurrent ICH. We compared demographic data, baseline clinical characteristics, imaging information, hematological parameters, and clinical outcomes between recurrent and first-ever ICH. We found that recurrent ICH was significantly associated with older age, more frequent history of ischemic heart disease, ischemic stroke, hypertension, and hyperlipidemia, while patients with recurrent ICH had previously received more antihypertensive therapy, and showed lower admission blood pressure (median, 160 vs. 167 mmHg) and higher baseline of National Institute of Health stroke scale (NIHSS) score (median, 10 vs. 9). We also demonstrated that recurrent ICH was an independent risk factor of 3-month function dependence after adjusting for many potentially competitive risk factors.
Collapse
Affiliation(s)
- Yan Wan
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Hongxiu Guo
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Rentang Bi
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Shaoli Chen
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jing Shen
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Man Li
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Yuanpeng Xia
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Lei Zhang
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Zhou Sun
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Xiaolu Chen
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Zhuoyuan Cai
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Zhaowei Wang
- Department of Neurology, Qianjiang Central Hospital, Qianjiang, China
| | - Daokai Gong
- Department of Neurology, Jingzhou Central Hospital, Jingzhou, China
| | - Jingwen Xu
- Department of Neurology, Honghu People’s Hospital, Honghu, China
| | - Dongya Zhu
- School of Pharmacy, Nanjing Medical University, Nanjing, China
| | - Bo Hu
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Bo Hu,
| | - Quanwei He
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- *Correspondence: Quanwei He,
| |
Collapse
|